A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies

Overview

Journal Vaccines (Basel)

Date 2020 Jun 14

PMID 32532141

Citations 6

Authors

Jean Claude Balingit

Minh Huong Phu Ly

Mami Matsuda

Ryosuke Suzuki

Futoshi Hasebe

Kouichi Morita

Meng Ling Moi

Affiliations

Soon will be listed here.

Abstract

Mosquito-borne flavivirus infections, including dengue virus and Zika virus, are major public health threats globally. While the plaque reduction neutralization test (PRNT) is considered the gold standard for determining neutralizing antibody levels to flaviviruses, the assay is time-consuming and laborious. This study, therefore, aimed to develop an enzyme-linked immunosorbent assay (ELISA)-based microneutralization test (EMNT) for the detection of neutralizing antibodies to mosquito-borne flaviviruses. The inhibition of viral growth due to neutralizing antibodies was determined colorimetrically by using EMNT. Given the significance of Fcγ-receptors (FcγR) in antibody-mediated neutralization and antibody-dependent enhancement (ADE) of flavivirus infection, non-FcγR and FcγR-expressing cell lines were used in the EMNT to allow the detection of the sum of neutralizing and immune-enhancing antibody activity as the neutralizing titer. Using anti-flavivirus monoclonal antibodies and clinical samples, the utility of EMNT was evaluated by comparing the end-point titers of the EMNT and the PRNT. The correlation between EMNT and PRNT titers was strong, indicating that EMNT was robust and reproducible. The new EMNT assay combines the biological functional assessment of virus neutralization activity and the technical advantages of ELISA and, is simple, reliable, practical, and could be automated for high-throughput implementation in flavivirus surveillance studies and vaccine trials.

Citing Articles

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody.

Keelapang P, Kraivong R, Pulmanausahakul R, Sriburi R, Prompetchara E, Kaewmaneephong J Microbiol Spectr. 2023; 11(4):e0091823.

PMID: 37409936 PMC: 10433959. DOI: 10.1128/spectrum.00918-23.

Trends in ELISA-Based Flavivirus IgG Serosurveys: A Systematic Review.

Vista F, Tantengco O, Dispo M, Opiso D, Badua C, Gerardo J Trop Med Infect Dis. 2023; 8(4).

PMID: 37104349 PMC: 10143827. DOI: 10.3390/tropicalmed8040224.

A Review on Tetrabromobisphenol A: Human Biomonitoring, Toxicity, Detection and Treatment in the Environment.

Miao B, Yakubu S, Zhu Q, Issaka E, Zhang Y, Adams M Molecules. 2023; 28(6).

PMID: 36985477 PMC: 10054480. DOI: 10.3390/molecules28062505.

Novel Antiviral Efficacy of and Extracts against Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Infection and Immunoregulatory Cytokine Signatures.

Mao Z, Minakawa N, Moi M Plants (Basel). 2022; 11(19).

PMID: 36235456 PMC: 9571899. DOI: 10.3390/plants11192589.

Discrepancies in Infectivity of Flavivirus and SARS-CoV-2 Clinical Samples: An Improved Assay for Infectious Virus Shedding and Viremia Assessment.

Fukuta M, Nguyen C, Nguyen T, Nguyen T, Vu T, Takemura T Int J Environ Res Public Health. 2021; 18(18).

PMID: 34574767 PMC: 8465741. DOI: 10.3390/ijerph18189845.

References

Moi M, Lim C, Kotaki A, Takasaki T, Kurane I . Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA. J Virol Methods. 2009; 163(2):205-9. DOI: 10.1016/j.jviromet.2009.09.018. View

Shan C, Xie X, Ren P, Loeffelholz M, Yang Y, Furuya A . A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients. EBioMedicine. 2017; 17:157-162. PMC: 5360589. DOI: 10.1016/j.ebiom.2017.03.006. View

Shan C, Ortiz D, Yang Y, Wong S, Kramer L, Shi P . Evaluation of a Novel Reporter Virus Neutralization Test for Serological Diagnosis of Zika and Dengue Virus Infection. J Clin Microbiol. 2017; 55(10):3028-3036. PMC: 5625389. DOI: 10.1128/JCM.00975-17. View

Whiteman M, Bogardus L, Giacone D, Rubinstein L, Antonello J, Sun D . Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue. Am J Trop Med Hyg. 2018; 99(6):1430-1439. PMC: 6283513. DOI: 10.4269/ajtmh.17-0948. View

Moi M, Lim C, Chua K, Takasaki T, Kurane I . Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells. PLoS Negl Trop Dis. 2012; 6(2):e1536. PMC: 3289619. DOI: 10.1371/journal.pntd.0001536. View

Roehrig J, Hombach J, Barrett A . Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Viral Immunol. 2008; 21(2):123-32. DOI: 10.1089/vim.2008.0007. View

Pham A, Langlois R, tenOever B . Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog. 2012; 8(1):e1002465. PMC: 3252368. DOI: 10.1371/journal.ppat.1002465. View

Gan E, Ting D, Chan K . The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis. Expert Rev Anti Infect Ther. 2016; 15(2):111-119. DOI: 10.1080/14787210.2017.1254550. View

Nealon J, Taurel A, Yoksan S, Moureau A, Bonaparte M, Quang L . Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries. J Infect Dis. 2018; 219(3):375-381. PMC: 6325342. DOI: 10.1093/infdis/jiy513. View

10.

Chan K, Ong E, Tan H, Zhang S, Zhang Q, Tang K . Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proc Natl Acad Sci U S A. 2014; 111(7):2722-7. PMC: 3932915. DOI: 10.1073/pnas.1317454111. View

11.

Buddhari D, Aldstadt J, Endy T, Srikiatkhachorn A, Thaisomboonsuk B, Klungthong C . Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies. PLoS Negl Trop Dis. 2014; 8(10):e3230. PMC: 4199527. DOI: 10.1371/journal.pntd.0003230. View

12.

Yen N, Duffy M, Hong N, Hien N, Fischer M, Hills S . Surveillance for Japanese encephalitis in Vietnam, 1998-2007. Am J Trop Med Hyg. 2010; 83(4):816-9. PMC: 2946747. DOI: 10.4269/ajtmh.2010.10-0262. View

13.

Halstead S . In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis. 1979; 140(4):527-33. DOI: 10.1093/infdis/140.4.527. View

14.

Katzelnick L, Harris E . Immune correlates of protection for dengue: State of the art and research agenda. Vaccine. 2017; 35(36):4659-4669. PMC: 5924688. DOI: 10.1016/j.vaccine.2017.07.045. View

15.

Koishi A, Suzukawa A, Zanluca C, Camacho D, Comach G, Duarte Dos Santos C . Development and evaluation of a novel high-throughput image-based fluorescent neutralization test for detection of Zika virus infection. PLoS Negl Trop Dis. 2018; 12(3):e0006342. PMC: 5871014. DOI: 10.1371/journal.pntd.0006342. View

16.

Capeding M, Tran N, Hadinegoro S, Ismail H, Chotpitayasunondh T, Chua M . Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014; 384(9951):1358-65. DOI: 10.1016/S0140-6736(14)61060-6. View

17.

Katzelnick L, Montoya M, Gresh L, Balmaseda A, Harris E . Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Proc Natl Acad Sci U S A. 2016; 113(3):728-33. PMC: 4725482. DOI: 10.1073/pnas.1522136113. View

18.

Kinoshita H, Mathenge E, Hung N, Huong V, Kumatori A, Yu F . Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient. Jpn J Infect Dis. 2009; 62(5):343-50. View

19.

Chawla T, Chan K, Zhang S, Tan H, Lim A, Hanson B . Dengue virus neutralization in cells expressing Fc gamma receptors. PLoS One. 2013; 8(5):e65231. PMC: 3661447. DOI: 10.1371/journal.pone.0065231. View

20.

Vorndam V, Beltran M . Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses. Am J Trop Med Hyg. 2002; 66(2):208-12. DOI: 10.4269/ajtmh.2002.66.208. View